NASDAQ (USD): Nurix Therapeutics, Inc. (NRIX)
Last Price
25.58
Today's Change
+0.71 (2.85%)
Day's Change
24.44 - 25.82
Trading Volume
214,570
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
12
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
Boeing’s Endless Problems Give Headache to New CEO Ortberg
2
US Could Cap Exports of AI Chips From Nvidia and AMD to Some Countries — Bloomberg
3
Emirates Blasts Boeing for Delays, Plans ‘serious Conversations’
4
Nvidia Rides Fierce Blackwell Demand Towards Stock Record Again
5
Warner Bros Discovery to Launch Max Streaming in Seven Asian Markets in November
#
Stock
Score
COP
ConocoPhillips
NVDA
NVIDIA Corporation
620
AGN
300
FDX
FedEx Corporation
DPST
Direxion Daily Regional Banks Bull 3X Shares
6
PLTR
Palantir Technologies Inc.
280
7
PIKE
200
8
TQQQ
ProShares UltraPro QQQ
9
CUBE
CubeSmart
10
AMD
Advanced Micro Devices, Inc.
Last
Change
Volume
133.91
+2.31
135,126,554
LMDX
0.016
-0.018
120,553,903
VS
4.90
+3.77
97,198,118
762.00
-84.71
85,558,284
SQQQ
7.34
+0.065
70,158,675
ATNF
10.23
+8.71
68,563,979
CTCX
0.51
+0.135
54,037,356
STEC
1.97
+1.60
52,129,454
SOXL
34.67
+0.205
48,210,916
QNRX
1.04
+0.535
44,592,105
BRK-A
698,565.52
+4,951.50
832
NVR
9,926.57
+158.28
4,045
KRRO
90.07
+50.31
869,760
AZO
3,129.43
+29.43
43,046
GWW
1,113.14
+27.57
82,823
FCNCA
2,050.30
+23.72
11,024
TPL
1,058.07
+21.40
19,213
URI
851.15
+17.47
151,159
UNH
573.44
+17.15
2,667,920
BKNG
4,323.47
+15.70
47,699
MELI
1,629.32
-188.66
1,851,535
MSTR
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
MPWR
838.63
-96.05
902,546
NOW
643.29
-87.83
5,025,012
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
ASML
689.08
-41.35
5,905,473
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....